Skip to content

Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients At Nutritional Risk

Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients At Nutritional Risk Receiving Dietary Counseling: a Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02763904
Enrollment
220
Registered
2016-05-05
Start date
2016-07-30
Completion date
2024-07-30
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Support

Brief summary

Protein-calorie malnutrition is a frequent comorbidity in hospitalized patients and there is evidence that the nutritional status may influence the response to drug treatment, mortality, susceptibility to infections, the patient's functional status, duration of hospital stay and, consequently, overall healthcare costs. The causes of malnutrition are manifold. The underlying disease may in fact lead to an increase in the patient's energy needs, whether or not associated with a reduction in caloric intake. The same therapeutic treatments can further worsen the energy balance without considering that the patient can be kept fasting for the execution of some diagnostic procedures. Therefore, a further deterioration of nutritional status during hospitalization could occur. International guidelines underline the utility to set a nutritional support whenever this is necessary, not only to prevent or treat malnutrition but also improve clinical outcomes. In this perspective, the improvement of oral diet and the use of oral nutritional supplements (ONS) represent the first-line strategy of intervention. Previous studies have shown that nutritional counseling, with or without the use of ONS, in patients with chronic disease is able to improve the calorie-protein intake, prevent deterioration of nutritional status, as well as to increase to a certain extent body weight. Particularly, energy-dense are more effective in increase energy intake. These data have highlighted the importance of a proper evaluation of the nutritional status of early detection of patients who could benefit of nutritional support. However, the independent role of the ONS in improving clinical outcome still needs to be established.

Interventions

Dietary counseling + energy-dense oral nutritional supplements since admission

OTHERDietary counseling

Dietary counseling alone. In case of inadequate energy intake patients will receive oral nutritional supplements since day 8 from admission (after the evaluation of the primary end point)

Sponsors

Emanuele Cereda
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Nutritional Risk Score \[NRS-2002\] ≥3 * assessed within 48 hours since admission * expected length of stay ≥7 days * written informed consent

Exclusion criteria

* age \< 18 years * ongoing or indication to artificial nutrition * severe hypophagia (intake \<50% of estimated requirements) * scheduled for surgery * indication to fasting * physician-based contra-indication to use of liquid oral nutritional supplements (vomitus, severe nausea, diarrhea, dysphagia) * physician-based indication to the of disease-specific oral nutritional supplements (e.g. kidney failure or pressure ulcers) * terminal illness * unavailability to planned measurements

Design outcomes

Primary

MeasureTime frameDescription
Body composition7 daysChange in phase angle as assessed by vectorial impedance analysis

Secondary

MeasureTime frameDescription
Body composition14 daysChange in phase angle as assessed by vectorial impedance analysis
Functional status7 daysChange in handgrip strength as assessed by dynamometry
Energy intake7 daysProtein-calorie intake as assessed by serial 24-hour dietary recall
InfectionsHospital stay, an average of 17 daysIncidence of new infections during the hospital stay
Adverse eventsHospital stay, an average of 17 daysGastrointestinal intolerance events

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026